TuHURA Biosciences (HURA) Competitors $2.66 +0.07 (+2.70%) Closing price 04:00 PM EasternExtended Trading$2.60 -0.06 (-2.07%) As of 05:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock HURA vs. ERAS, MBX, CGEM, KOD, PGEN, PRTC, RGNX, SVRA, KMDA, and CMPXShould you be buying TuHURA Biosciences stock or one of its competitors? The main competitors of TuHURA Biosciences include Erasca (ERAS), MBX Biosciences (MBX), Cullinan Therapeutics (CGEM), Kodiak Sciences (KOD), Precigen (PGEN), PureTech Health (PRTC), REGENXBIO (RGNX), Savara (SVRA), Kamada (KMDA), and Compass Therapeutics (CMPX). These companies are all part of the "pharmaceutical products" industry. TuHURA Biosciences vs. Its Competitors Erasca MBX Biosciences Cullinan Therapeutics Kodiak Sciences Precigen PureTech Health REGENXBIO Savara Kamada Compass Therapeutics TuHURA Biosciences (NASDAQ:HURA) and Erasca (NASDAQ:ERAS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment. Which has preferable valuation and earnings, HURA or ERAS? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTuHURA BiosciencesN/AN/A-$21.68MN/AN/AErascaN/AN/A-$161.65M-$0.62-2.42 Do analysts recommend HURA or ERAS? TuHURA Biosciences currently has a consensus price target of $12.67, suggesting a potential upside of 376.19%. Erasca has a consensus price target of $4.57, suggesting a potential upside of 204.76%. Given TuHURA Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe TuHURA Biosciences is more favorable than Erasca.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TuHURA Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.40Erasca 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor HURA or ERAS? In the previous week, Erasca had 3 more articles in the media than TuHURA Biosciences. MarketBeat recorded 3 mentions for Erasca and 0 mentions for TuHURA Biosciences. Erasca's average media sentiment score of 0.50 beat TuHURA Biosciences' score of 0.00 indicating that Erasca is being referred to more favorably in the news media. Company Overall Sentiment TuHURA Biosciences Neutral Erasca Neutral Do institutionals and insiders hold more shares of HURA or ERAS? 0.6% of TuHURA Biosciences shares are held by institutional investors. Comparatively, 67.8% of Erasca shares are held by institutional investors. 0.2% of TuHURA Biosciences shares are held by company insiders. Comparatively, 14.4% of Erasca shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is HURA or ERAS more profitable? TuHURA Biosciences' return on equity of 291.69% beat Erasca's return on equity.Company Net Margins Return on Equity Return on Assets TuHURA BiosciencesN/A 291.69% 122.09% Erasca N/A -36.56%-31.08% Which has more risk & volatility, HURA or ERAS? TuHURA Biosciences has a beta of 0.04, meaning that its share price is 96% less volatile than the S&P 500. Comparatively, Erasca has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500. SummaryTuHURA Biosciences and Erasca tied by winning 6 of the 12 factors compared between the two stocks. Get TuHURA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HURA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HURA vs. The Competition Export to ExcelMetricTuHURA BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$116.19M$3.02B$5.54B$9.44BDividend YieldN/A2.46%4.73%4.14%P/E RatioN/A17.8028.9624.32Price / SalesN/A186.59376.0979.56Price / CashN/A40.5624.4827.20Price / Book7.829.008.655.84Net Income-$21.68M-$54.98M$3.24B$264.73M7 Day Performance-0.75%2.07%0.45%-1.00%1 Month Performance7.69%17.22%8.25%6.08%1 Year PerformanceN/A14.94%30.15%23.78% TuHURA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HURATuHURA Biosciences1.2922 of 5 stars$2.66+2.7%$12.67+376.2%N/A$116.19MN/A0.00N/AERASErasca1.9354 of 5 stars$1.70-2.3%$4.57+168.9%-48.8%$492.92MN/A-2.74120News CoverageUpcoming EarningsMBXMBX Biosciences2.7861 of 5 stars$14.55-0.1%$37.57+158.2%N/A$486.32MN/A0.0036News CoverageAnalyst ForecastCGEMCullinan Therapeutics2.1679 of 5 stars$8.23+0.6%$30.00+264.5%-55.3%$482.74MN/A-2.8330Upcoming EarningsKODKodiak Sciences3.2709 of 5 stars$8.24-6.8%$9.00+9.2%+172.8%$466.43MN/A-2.2790Positive NewsPGENPrecigen4.0046 of 5 stars$1.58+0.6%$6.00+279.7%+27.5%$463.43M$3.92M-2.82190PRTCPureTech Health1.4478 of 5 stars$19.09+0.1%$45.00+135.8%-12.2%$458.15M$4.83M0.00100Gap DownRGNXREGENXBIO4.1331 of 5 stars$8.79-1.9%$31.63+259.8%-36.1%$449.44M$83.33M-2.83370Upcoming EarningsSVRASavara2.0158 of 5 stars$2.66+3.1%$5.60+110.5%-38.2%$445.92MN/A-5.5420News CoverageUpcoming EarningsHigh Trading VolumeKMDAKamada4.4623 of 5 stars$7.68-0.5%$13.00+69.3%+33.6%$443.94M$160.95M26.48360Positive NewsCMPXCompass Therapeutics2.9086 of 5 stars$3.20+0.6%$12.67+295.8%+186.3%$439.74M$850K-7.8020News CoverageUpcoming Earnings Related Companies and Tools Related Companies ERAS Competitors MBX Competitors CGEM Competitors KOD Competitors PGEN Competitors PRTC Competitors RGNX Competitors SVRA Competitors KMDA Competitors CMPX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HURA) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TuHURA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TuHURA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HURA Stock Alerts